HASTINGS DAVID C
CIK: 0001237401
Director
Primary company: INCYTE CORP (INCY)
HASTINGS DAVID C is a corporate insider at INCYTE CORP (INCY) filing SEC Form 4 transactions. 136 transactions across 5 companies, totaling $93,919 in purchases and $36,295,743 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 23,000 | 6/26/2025 Filed: 6/30/2025 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 69,183 | 6/26/2025 Filed: 6/30/2025 | Filing → |
| Award | 365,800 | $3.29 | $1.20M | 365,800 | 2/14/2025 Filed: 2/19/2025 | Filing → | |
| Award | 90,100 | - | - | 249,824 | 2/14/2025 Filed: 2/19/2025 | Filing → | |
| Sale | 22,183 | $3.28 | $73K | 159,724 | 2/4/2025 Filed: 2/5/2025 | Filing → | |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 23,000 | 6/20/2024 Filed: 6/21/2024 | Filing → |
SCYNEXIS INC SCYX | Award | 23,000 | - | - | 46,183 | 6/20/2024 Filed: 6/21/2024 | Filing → |
| Sale | 9,593 | $2.31 | $22K | 181,907 | 2/2/2024 Filed: 2/5/2024 | Filing → | |
| Award | 450,000 | - | - | 450,000 | 2/1/2024 Filed: 2/5/2024 | Filing → | |
| Award | 112,500 | - | - | 191,500 | 2/1/2024 Filed: 2/5/2024 | Filing → | |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 23,183 | 6/15/2023 Filed: 6/23/2023 | Filing → |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 10,000 | 6/15/2023 Filed: 6/20/2023 | Filing → |
| Award | 316,000 | $0.00 | $0 | 316,000 | 2/1/2023 Filed: 2/3/2023 | Filing → | |
| Award | 79,000 | $0.00 | $0 | 79,000 | 2/1/2023 Filed: 2/3/2023 | Filing → | |
Entasis Therapeutics Holdings Inc. ETTX | J | 11,000 | $0.00 | $0 | 0 | 7/11/2022 Filed: 7/11/2022 | Filing → |
Entasis Therapeutics Holdings Inc. ETTX | J | 26,583 | $0.00 | $0 | 0 | 7/11/2022 Filed: 7/11/2022 | Filing → |
Entasis Therapeutics Holdings Inc. ETTX | Disposition | 27,500 | $2.20 | $61K | 0 | 7/11/2022 Filed: 7/11/2022 | Filing → |
Entasis Therapeutics Holdings Inc. ETTX | U | 22,000 | $2.20 | $48K | 0 | 7/7/2022 Filed: 7/11/2022 | Filing → |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 10,000 | 6/17/2022 Filed: 6/22/2022 | Filing → |
SCYNEXIS INC SCYX | Award | 10,000 | $0.00 | $0 | 13,183 | 6/17/2022 Filed: 6/22/2022 | Filing → |
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
Type
Award
Shares
365,800
Price
$3.29
Value
$1.20M
Type
Award
Shares
90,100
Price
-
Value
-
Type
Sale
Shares
22,183
Price
$3.28
Value
$73K
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
23,000
Price
-
Value
-
Type
Sale
Shares
9,593
Price
$2.31
Value
$22K
Type
Award
Shares
450,000
Price
-
Value
-
Type
Award
Shares
112,500
Price
-
Value
-
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
Type
Award
Shares
316,000
Price
$0.00
Value
$0
Type
Award
Shares
79,000
Price
$0.00
Value
$0
Entasis Therapeutics Holdings Inc.
ETTX
Type
J
Shares
11,000
Price
$0.00
Value
$0
Entasis Therapeutics Holdings Inc.
ETTX
Type
J
Shares
26,583
Price
$0.00
Value
$0
Entasis Therapeutics Holdings Inc.
ETTX
Type
Disposition
Shares
27,500
Price
$2.20
Value
$61K
Entasis Therapeutics Holdings Inc.
ETTX
Type
U
Shares
22,000
Price
$2.20
Value
$48K
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
SCYNEXIS INC
SCYX
Type
Award
Shares
10,000
Price
$0.00
Value
$0
AI Agent
Try asking...